PERIOPERATIVE NUTRITIONAL STATUS
Journal Title: Romanian Journal of Diabetes Nutrition and Metabolic Diseases - Year 2011, Vol 18, Issue 4
Abstract
Malnutrition is defined as the pathological state in which the nutritional intake is insufficient, excessive or ill-balanced and represents a frequent problem among hospitalized patients. The risk factors involved in the development of malnutrition are related to the patient, the amplitude of the surgical gesture and the non-surgical treatment. The evaluation of the nutritional status in the perioperative period using clinical and paraclinical parameters is essential. Based on the parameters, bio-clinical scores such as the Nutritional Risk Index or the Subjective Global Assessment, which establish the risk for perioperative complications, were composed. The medico-surgical collaboration which includes ICU-specialists, nutritionists and surgeons is essential for the investigation of the nutritional status, determining the time of the intervention and the necessity for nutritional support.
Authors and Affiliations
Vlad Andrei Nechifor, Denis Iulian Trufa, Cătălin Marian Ciuta, Lidia Iuliana Graur, Iulia Potorac, Mariana Graur
Keywords
Related Articles
- EP ID EP119369
- DOI -
- Views 100
- Downloads 0
LET’S DISCUSS ABOUT SOME ASPECTS OF THE DIABETES EPIDEMIOLOGY IN ROMANIA
THE VALUE OF DIFFERENT ANTHROPOMETRIC VARIABLES IN ASSESSING CARDIOMETABOLIC RISK
Objective. To investigate which anthropometric parameter best correlates with modifications in blood glucose and blood pressure (BP). Material and method. 135 subjects were included in the study. We measured weight, heig...
HYPOGLYCEMIA IN CHILDREN WITH TYPE 1 DIABETES MELLITUS
HEPATIC FIBROSIS, MEASURED BY FIBROSCANIN A GROUP OF PATIENTS WITH OBESITY
Introduction. Hepatic steatosis is a reversible condition caused by accumulation of triglycerides in liver cells. Non-alcoholic fatty liver disease (NAFLD) can progress to advanced liver disease: fibrosis, cirrhosi...
Therapeutical Options For Optimizing The Glycemic Profile In A Patient With T2DM
Incretin-based therapies address some of the mechanisms of T2DM by improving β-cell function, inhibiting glucagon secretion, stimulating insulin secretion, reducing appetite and promoting weight loss. We present the case...